Catalyst
Monitor the closing of the transaction, expected in the second half of the year, and subsequent integration of PathAI's technology into Roche's offerings.
Humanexa recommends Monitor.
Date
June 16, 2026
Phase
N/A
Status
watch
Signal score
8.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.